Neoadjuvant Chemotherapy for the Treatment of Patients With Bladder Cancer Alexander Kutikov, MD, FACS, attending surgeon, Urologic Oncology, associate professor, Urologic Oncology, Fox Chase Cancer Center, discusses neoadjuvant chemotherapy for the treatment of patients with bladder cancer. Kutikov and his colleagues feel it is best for patients to be treated with chemotherapy before surgery because the surgery continues to have limitations. About 20% to 30% of patients have a chance of recurrence. Neoadjuvant chemotherapy is also recommended due to the fact that there is no significant harm for patients.